Table 4 Study schedule and assessments
Timepoint → | -t1 | t 0 | t 1 | t 2 | |||
|---|---|---|---|---|---|---|---|
Visit # → | 0 | 1 | 2 | 3 | |||
Week # → | -1 to -3 | 0 | 4 | 8 | 12 | 24 | |
ENROLMENT: Screening & inclusion assessments | |||||||
Regular clinical intake | X | ||||||
Demographics | X | ||||||
Inclusion/exclusion | X | ||||||
National Adult Reading Task | X | ||||||
Montreal Cognitive Assessment | X | ||||||
Epworth Sleepiness | X | ||||||
Levodopa equivalent dose (LED) | X | X | X | ||||
ASSESSMENTS: Primary outcomes | |||||||
Standard neuropsychological battery | X | X | X | ||||
MyCQ™ assessment | X | X | X | X | X | ||
Additional outcomes | |||||||
Motor function (UPDRS part III) | X | X | X | ||||
Self-report questionnaires | X | X | X | ||||
Parkinson Disease Questionnaire-39 | X | X | X | ||||
Pre-Rasch-built Overall Disability Scale | X | X | X | ||||
fMRI exclusion criteria | X | ||||||
fMRI scan | X | X | |||||
INTERVENTIONS | |||||||
Randomization | X | ||||||
Game playing (36 sessions of 30 min) | X | X | X | X | X | ||